About MCRC

This author has not yet filled in any details.
So far MCRC has created 135 blog entries.
  • Vero

Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals

VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that it is doubling down on its commitment to support the treatment of patients afflicted with complications of COVID with GENOSYL® DS, the first and only FDA-approved tankless system for the delivery of inhaled nitric oxide.  Click here to read full press release.

By |2020-05-14T22:58:06+00:00April 8th, 2020|News|Comments Off on Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals
  • Vero

FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1.  Click here to read full press release.

By |2020-05-14T22:58:51+00:00March 26th, 2020|News|Comments Off on FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
  • Vero

VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

Treatment informs FDA approval for emergency expanded access use for GENOSYL® inhaled nitric oxide.  Click here to read full press release.

By |2020-05-14T22:59:25+00:00March 24th, 2020|News|Comments Off on VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
  • Xtalic

Xtalic’s Nanostructured Nickel-Gold Alloy Enables Fine Pitch Interconnects to Carry More Current, Maintain Strength at Higher Temperatures

MARLBOROUGH, MASSACHUSETTS, USA — March 11, 2020 — Xtalic Corporation announces a new patented, nanostructured nickel-gold (Ni-Au) alloy for use in the manufacture of crucial electrical contacts where high conductivity and strength must be maintained at elevated temperatures.  Click here to read full press release.

By |2020-05-14T22:49:34+00:00March 11th, 2020|News|Comments Off on Xtalic’s Nanostructured Nickel-Gold Alloy Enables Fine Pitch Interconnects to Carry More Current, Maintain Strength at Higher Temperatures
  • Segue

Segue Manufacturing Services LLC Receives 2020 Best of Lowell Award Lowell Award Program Honors the Achievement

LOWELL January 14, 2020 -- Segue Manufacturing Services LLC has been selected for the 2020 Best of Lowell Award in the Electronic Parts Supplier category by the Lowell Award Program.  Click here to read press release.

By |2020-05-14T22:43:49+00:00January 14th, 2020|News|Comments Off on Segue Manufacturing Services LLC Receives 2020 Best of Lowell Award Lowell Award Program Honors the Achievement